Published in J Heart Lung Transplant on November 01, 2010
WHO's in second?: A practical review of World Health Organization group 2 pulmonary hypertension. Chest (2013) 4.24
Pulmonary hypertension related to left-sided cardiac pathology. Pulm Med (2011) 0.91
Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device. J Artif Organs (2012) 0.84
Acute pulmonary vasoreactivity test with sildenafil or nitric monoxide before left ventricular assist device implantation. J Artif Organs (2013) 0.80
A heart transplant candidate with severe pulmonary hypertension and extremely high pulmonary vascular resistance. J Artif Organs (2013) 0.77
Fixed pulmonary hypertension and mechanical support: an unclear opportunity. J Heart Lung Transplant (2011) 0.75
Pulmonary Hypertension in the Era of Mechanical Circulatory Support. ASAIO J (2016) 0.75
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol (2006) 3.20
Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA (2007) 2.89
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation (2005) 2.81
Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review. Circ Heart Fail (2013) 2.50
Skeletonization of bilateral internal thoracic artery grafts lowers the risk of sternal infection in patients with diabetes. J Thorac Cardiovasc Surg (2003) 2.39
Are stentless valves hemodynamically superior to stented valves? A prospective randomized trial. Ann Thorac Surg (2002) 2.30
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. J Am Coll Cardiol (2011) 2.29
Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg (2005) 2.24
Extended heart failure clinic follow-up in low-risk patients: a randomized clinical trial (NorthStar). Eur Heart J (2012) 2.21
Left ventricular reconstruction: Early and late results. J Thorac Cardiovasc Surg (2004) 2.06
Mobile phone-based telemonitoring for heart failure management: a randomized controlled trial. J Med Internet Res (2012) 2.06
Calcium antagonists are associated with reduced mortality after cardiac surgery: a propensity analysis. J Thorac Cardiovasc Surg (2004) 2.03
High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors. J Hypertens (2006) 2.03
Evaluation of a novel transfusion algorithm employing point-of-care coagulation assays in cardiac surgery: a retrospective cohort study with interrupted time-series analysis. Anesthesiology (2015) 2.02
Highly sensitized patients in cardiac transplantation: early outcomes from the Canadian Prioritized Organ Sharing Program. J Heart Lung Transplant (2012) 2.01
Effect of increasing pump speed during exercise on peak oxygen uptake in heart failure patients supported with a continuous-flow left ventricular assist device. A double-blind randomized study. Eur J Heart Fail (2014) 1.99
Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation (2012) 1.91
The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol (2011) 1.78
Increased ventricular repolarization heterogeneity in patients with ventricular arrhythmia vulnerability and cardiomyopathy: a human in vivo study. Am J Physiol Heart Circ Physiol (2005) 1.78
Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential. CMAJ (2006) 1.73
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol (2007) 1.70
PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function. Proc Natl Acad Sci U S A (2011) 1.70
Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol (2009) 1.62
Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs. Mol Microbiol (2003) 1.62
Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD. Am J Kidney Dis (2006) 1.61
Redo valvular surgery in elderly patients. Ann Thorac Surg (2009) 1.61
Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure. Eur J Heart Fail (2014) 1.60
Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol (2009) 1.51
N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery. Crit Care Med (2009) 1.51
Fundamentals of reperfusion injury for the clinical cardiologist. Circulation (2002) 1.49
Off-pump coronary artery surgery for reducing mortality and morbidity: meta-analysis of randomized and observational studies. J Am Coll Cardiol (2005) 1.49
Perceptions and experiences of heart failure patients and clinicians on the use of mobile phone-based telemonitoring. J Med Internet Res (2012) 1.48
Which patient, which pump? J Heart Lung Transplant (2003) 1.46
Calcium antagonists reduce cardiovascular complications after cardiac surgery: a meta-analysis. J Am Coll Cardiol (2003) 1.45
Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex. J Hypertens (2008) 1.45
The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol (2012) 1.44
To STICH or not to STICH: we know the answer, but do we understand the question? J Thorac Cardiovasc Surg (2005) 1.44
High mortality among heart failure patients treated with antidepressants. Int J Cardiol (2010) 1.42
Circulating proangiogenic progenitor cells independently predict functional capacity in heart failure patients. Can J Cardiol (2012) 1.41
[The Mechanical Heart--HeartMate 1--Danish results]. Ugeskr Laeger (2007) 1.40
Paroxysmal atrial fibrillation is uncommon in outpatients with chronic heart failure. Scand Cardiovasc J (2008) 1.40
Donor pretreatment with hypertonic saline attenuates primary allograft dysfunction: a pilot study in a porcine model. Circulation (2009) 1.39
[Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases]. Ugeskr Laeger (2004) 1.38
Attitudes of heart failure patients and health care providers towards mobile phone-based remote monitoring. J Med Internet Res (2010) 1.34
Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. Eur Heart J (2012) 1.33
N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension (2005) 1.31
N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J (2007) 1.30
Non-utilization of hearts and lungs after consent for donation: a Canadian multicentre study. Can J Anaesth (2006) 1.25
Increased endothelin-1 production in diabetic patients after cardioplegic arrest and reperfusion impairs coronary vascular reactivity: reversal by means of endothelin antagonism. J Thorac Cardiovasc Surg (2002) 1.24
Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience. J Thorac Cardiovasc Surg (2004) 1.23
Optical mapping of Langendorff-perfused human hearts: establishing a model for the study of ventricular fibrillation in humans. Am J Physiol Heart Circ Physiol (2007) 1.21
Cardiac surgery-associated acute kidney injury. Interact Cardiovasc Thorac Surg (2014) 1.19
Initial results of the chordal-cutting operation for ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2007) 1.19
Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: reversal with endothelin antagonism. J Thorac Cardiovasc Surg (2002) 1.18
The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant (2016) 1.16
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol (2008) 1.15
Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients. Circulation (2013) 1.15
An interactive Internet site for the management of patients with congestive heart failure. Can J Cardiol (2003) 1.14
Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway. Circulation (2006) 1.13
Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol (2005) 1.12
Predictors of low cardiac output syndrome after isolated aortic valve surgery. Circulation (2005) 1.11
Cardiac allograft vasculopathy: a review. Can J Surg (2005) 1.11
Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung. PLoS One (2008) 1.09
Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant (2009) 1.09
Stentless aortic valves are hemodynamically superior to stented valves during mid-term follow-up: a large retrospective study. Ann Thorac Surg (2005) 1.08
European results with a continuous-flow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg (2009) 1.07
Relation between aortic cross-clamp time and mortality--not as straightforward as expected. Eur J Cardiothorac Surg (2008) 1.07
Intramural activation during early human ventricular fibrillation. Circ Arrhythm Electrophysiol (2011) 1.06
How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure? J Card Fail (2004) 1.05
Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials. Eur J Clin Pharmacol (2010) 1.04
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol (2009) 1.04
Early changes in bioprosthetic heart valves following ventricular assist device implantation. Int J Cardiol (2007) 1.03
Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups. Eur J Heart Fail (2011) 1.02
Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant (2009) 1.01
Reoperative mitral valve replacement: importance of preservation of the subvalvular apparatus. Ann Thorac Surg (2002) 1.01
Quality of life and left ventricular assist device support. Circulation (2012) 1.01
Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure. Eur J Heart Fail (2011) 1.00
Long-term clinical variation of NT-proBNP in stable chronic heart failure patients. Eur Heart J (2007) 0.99
Parkinson-susceptibility gene DJ-1/PARK7 protects the murine heart from oxidative damage in vivo. Proc Natl Acad Sci U S A (2013) 0.99
Dexmedetomidine versus Propofol Sedation Reduces Delirium after Cardiac Surgery: A Randomized Controlled Trial. Anesthesiology (2016) 0.99
Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Anesthesiology (2006) 0.99
Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care. Eur Heart J (2010) 0.98
Concordance among pathologists in the second Cardiac Allograft Rejection Gene Expression Observational Study (CARGO II). Transplantation (2012) 0.98
Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction. Am J Cardiol (2005) 0.97
Choices: a study of preferences for end-of-life treatments in patients with advanced heart failure. J Heart Lung Transplant (2008) 0.95